Home › Research › Inflammation and the immune system
Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both?
Amit Sharma, Bhavin K Parekh, Vinay Patil, Renuka Jyothi S., Priya Priyadarshini Nayak, J Bethanney Janney, Gurjant Singh, Shaker Al-Hasnaawei. Developmental Neurobiology, 2025-10-31
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer's disease (AD), the most prevalent form of dementia, is neuropathologically defined by the accumulation of extracellular amyloid-beta (Aβ) plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau. Although traditionally viewed as a neuron-centric disorder, increasing evidence underscores the pivotal role of glial cells-particularly microglia and astrocytes-in AD pathogenesis. Once regarded as passive support cells, glia are now recognized as active participants in neuroinflammation, synaptic dysfunction, and disease progression. Microglia, the resident immune cells of the central nervous system, and astrocytes, key regulators of homeostasis and neurotransmission, undergo significant phenotypic changes in response to AD pathology. These include polarization into pro-inflammatory states, impaired clearance of pathological proteins, and detrimental cross talk that amplifies neuroinflammation and neuronal injury. This review synthesizes current literature on the dualistic roles of glial cells in AD, highlighting their contributions to Aβ and tau pathology, synapse loss, demyelination, neurotransmission deficits, and the neuroinflammatory cycle. Emphasis is placed on the dynamic polarization of glia, the reciprocal interactions between microglia and astrocytes, and their combined impact on neurodegeneration. We further explore both pharmacological and non-pharmacological therapeutic approaches targeting glial function, including anti-inflammatory agents, senolytics, deep brain stimulation, exercise, and dietary interventions. By elucidating the multifaceted involvement of glial cells in AD, this review aims to spotlight emerging therapeutic strategies that go beyond neuronal targets, offering new hope for modifying disease progression and improving patient outcomes.
What this study adds
Evidence grade: Low
This review describes how microglia and astrocytes change in Alzheimer's disease and can both protect and harm the brain through inflammation and other processes. It frames glial cells as active participants in disease progression but does not report a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Sharma, A., Parekh, B. K., Patil, V., Renuka Jyothi, S., Nayak, P. P., Janney, J. B., et al. (2025). Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both? Developmental Neurobiology. https://doi.org/10.1002/dneu.23015
Vancouver
Sharma A, Parekh BK, Patil V, Renuka Jyothi S, Nayak PP, Janney JB, et al. Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both? Developmental Neurobiology. 2025. doi:10.1002/dneu.23015. PMID: 41171842.
BibTeX
@article{sharma2025-41171842,
author = {Sharma, Amit and Parekh, Bhavin K and Patil, Vinay and Renuka Jyothi, S. and Nayak, Priya Priyadarshini and Janney, J Bethanney and Singh, Gurjant and Al-Hasnaawei, Shaker},
title = {{Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both?}},
journal = {Developmental Neurobiology},
year = {2025},
doi = {10.1002/dneu.23015},
pmid = {41171842},
url = {https://doi.org/10.1002/dneu.23015}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Microglia, the resident immune cells of the central nervous system, and astrocytes, key regulators of homeostasis and neurotransmission, undergo significant phenotypic changes in response to AD pathology.
Why it matters
This review describes how microglia and astrocytes change in Alzheimer's disease and can both protect and harm the brain through inflammation and other processes. It frames glial cells as active participants in disease progression but does not report a treatment or cure.
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Developmental Neurobiology) |
| Journal's citation record | 1 / 4 | Developmental Neurobiology: journal h-index 100 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 14 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 4.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 14 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Shaker Al-Hasnaawei: h-index 9 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Siksha O Anusandhan University: institution h-index 195 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41171842) |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/dneu.23015
- PubMed: 41171842
- Original source →
- Free full text: Developmental Neurobiology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 31.
Related studies in Inflammation and the immune system from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.